| Hope-fullness Counseling, Prevention, And Education | |
|
25 W Park Ave Belford NJ 07718-1046 | |
| (732) 687-9796 | |
| (732) 769-2397 |
| Full Name | Hope-fullness Counseling, Prevention, And Education |
|---|---|
| Speciality | Community/Behavioral Health |
| Location | 25 W Park Ave, Belford, New Jersey |
| Authorized Official Name and Position | Nicole Tierney (SOLE MEMBER) |
| Authorized Official Contact | 7326879796 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Hope-fullness Counseling, Prevention, And Education 25 W Park Ave Belford NJ 07718-1046 Ph: (732) 687-9796 | Hope-fullness Counseling, Prevention, And Education 25 W Park Ave Belford NJ 07718-1046 Ph: (732) 687-9796 |
| NPI Number | 1063123180 |
|---|---|
| Provider Enumeration Date | 12/09/2022 |
| Last Update Date | 12/09/2022 |
| Certification Date | 12/09/2022 |
| Medicare PECOS PAC ID | 0042660896 |
|---|---|
| Medicare Enrollment ID | O20231220001881 |
News Archive
INVO Bioscience, Inc., a medical device company focused on treatment options for patients diagnosed with infertility, today announced the signing of an exclusive sales and distribution agreement with the Biodar Plus Company, based in Donetsk, Ukraine to distribute the INVOcell product throughout Ukraine and to provide the INVO Bioscience infertility treatments in its in-house infertility center.
An intensive lifestyle intervention program designed to achieve and maintain weight loss improves diabetes control and cardiovascular disease risk factors in overweight and obese individuals with type 2 diabetes, according to four-year results of the Look AHEAD study, funded by the National Institutes of Health and the Centers for Disease Control and Prevention. The results are published in the Sept. 27, 2010, issue of the Archives of Internal Medicine.
Mayo Clinic announces the launch of CANCP, a new gene panel cancer test to help tailor chemotherapy to the individual patient based on the unique genomic signature of the patient's tumor.
Researchers from the Experimental Oncology Group, led by Mariano Barbacid at the Spanish National Cancer Research Centre, have published in Cancer Cell the results of a study that shows full regression of advanced pancreatic ductal adenocarcinoma upon combined inhibition of the epidermal growth factor receptor and c-RAF kinase.
The national health care debate is far from over. Days removed from his televised national health care forum, President Obama is calling for an "up or down" vote on the measure within the next few weeks.
› Verified 2 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063123180 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 251S00000X | Community/behavioral Health | (* (Not Available)) | Primary |
| Provider Name | Nicole Tierney |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1861101768 PECOS PAC ID: 0941650790 Enrollment ID: I20231220001967 |
News Archive
INVO Bioscience, Inc., a medical device company focused on treatment options for patients diagnosed with infertility, today announced the signing of an exclusive sales and distribution agreement with the Biodar Plus Company, based in Donetsk, Ukraine to distribute the INVOcell product throughout Ukraine and to provide the INVO Bioscience infertility treatments in its in-house infertility center.
An intensive lifestyle intervention program designed to achieve and maintain weight loss improves diabetes control and cardiovascular disease risk factors in overweight and obese individuals with type 2 diabetes, according to four-year results of the Look AHEAD study, funded by the National Institutes of Health and the Centers for Disease Control and Prevention. The results are published in the Sept. 27, 2010, issue of the Archives of Internal Medicine.
Mayo Clinic announces the launch of CANCP, a new gene panel cancer test to help tailor chemotherapy to the individual patient based on the unique genomic signature of the patient's tumor.
Researchers from the Experimental Oncology Group, led by Mariano Barbacid at the Spanish National Cancer Research Centre, have published in Cancer Cell the results of a study that shows full regression of advanced pancreatic ductal adenocarcinoma upon combined inhibition of the epidermal growth factor receptor and c-RAF kinase.
The national health care debate is far from over. Days removed from his televised national health care forum, President Obama is calling for an "up or down" vote on the measure within the next few weeks.
› Verified 2 days ago
News Archive
INVO Bioscience, Inc., a medical device company focused on treatment options for patients diagnosed with infertility, today announced the signing of an exclusive sales and distribution agreement with the Biodar Plus Company, based in Donetsk, Ukraine to distribute the INVOcell product throughout Ukraine and to provide the INVO Bioscience infertility treatments in its in-house infertility center.
An intensive lifestyle intervention program designed to achieve and maintain weight loss improves diabetes control and cardiovascular disease risk factors in overweight and obese individuals with type 2 diabetes, according to four-year results of the Look AHEAD study, funded by the National Institutes of Health and the Centers for Disease Control and Prevention. The results are published in the Sept. 27, 2010, issue of the Archives of Internal Medicine.
Mayo Clinic announces the launch of CANCP, a new gene panel cancer test to help tailor chemotherapy to the individual patient based on the unique genomic signature of the patient's tumor.
Researchers from the Experimental Oncology Group, led by Mariano Barbacid at the Spanish National Cancer Research Centre, have published in Cancer Cell the results of a study that shows full regression of advanced pancreatic ductal adenocarcinoma upon combined inhibition of the epidermal growth factor receptor and c-RAF kinase.
The national health care debate is far from over. Days removed from his televised national health care forum, President Obama is calling for an "up or down" vote on the measure within the next few weeks.
› Verified 2 days ago
Ymca Of Greater Monmouth County Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 300 Leonardville Rd, Belford, NJ 07718 Phone: 732-290-9040 Fax: 732-566-0433 | |
Positive Behavior Supports Corp Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 317 Hollie Dr E, Belford, NJ 07718 Phone: 855-832-6727 Fax: 772-675-9100 | |
Healing Solutions, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 55 Leonardville Rd. - 2nd Floor, Belford, NJ 07718 Phone: 732-221-4074 | |
Caare Counseling And Consultation Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 597 Turner Dr, Belford, NJ 07718 Phone: 732-673-6054 |